Skip to content
FDAMedicines

American Regent, Inc. Animal Health Issues Nationwide Recall of Two Lots of Adequan® Canine and Two Lots of Adequan® I.M. Due to Visible Glass Fiber Material in the Product

FDA recall n-american-regent-inc-animal-health-issues-nationwide-recall-two-lots-adequanr-can ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

Check my lot or code

Is yours in this recall?

Type the lot, batch, date code, model number or UPC printed on the product. It is compared here, in your browser, with the codes this notice lists. It stays in this page: it is not added to the address.

General information on recalls from the agency: U.S. Food and Drug Administration (opens in a new tab).

What the agency says to do

FDA’s record gives no instruction for consumers.

Note from Recalls Watch, not agency text

Why it was recalled

Visible glass fiber material in the product
Text from FDA, unedited.

The recalled product

Codes in the record. Click one to copy it.

FOR IMMEDIATE RELEASE – July 31, 2026 – Shirley, NY, American Regent, Inc. Animal Health is conducting a nationwide recall of two lots (25011 and 3369) of Adequan® Canine Injection (for dogs), 100 mg/mL 5mL multi-dose vials and two lots (24416 and 25265P) of Adequan® i.m. Injection (for horses), 500
Text from FDA, unedited.

Company announcement, as FDA publishes it

FOR IMMEDIATE RELEASE – July 31, 2026 – Shirley, NY, American Regent, Inc. Animal Health is conducting a nationwide recall of two lots ( 25011 and 3369 ) of Adequan® Canine Injection (for dogs), 100 mg/mL 5mL multi-dose vials and two lots ( 24416 and 25265P ) of Adequan® i.m. Injection (for horses), 500mg/5 mL single-dose 5mL vials to the consumer level. The products are being recalled due to the presence of glass fibers found during testing of internally retained samples.

Risk Statement : The administration of an intramuscular injectable product containing particulate matter, such as glass fibers, may result in local irritation, swelling, inflammation, injection site pain, infection, or abscesses. To date, American Regent, Inc. has not received any reports of adverse events related to the recalled lots.

Both Adequan Canine and Adequan i.m. are clear, colorless to slightly yellow solutions. The products are for intramuscular injections and are to be used by or under the direction of a licensed veterinarian.

Adequan Canine is a prescription medication used in the treatment of non-infectious degenerative or traumatic joint dysfunction in dogs.

Adequan i.m. is a prescription medication used in the treatment of noninfectious degenerative or traumatic joint dysfunction and associated lameness in horses.

Adequan Canine Lot #’s 3369 and 25011 were distributed nationwide to online pharmacies, distributors/ wholesalers and veterinarians in the United States on 05/22/2024 and 04/14/2025 respectively and Adequan i.m. Lot #’s 24416 and 25265P were distributed nationwide to online pharmacies, distributors/ wholesalers and veterinarians in the United States on 05/08/2025 and 01/22/2026 respectively.

Any person or entity with the recalled product lots should not use the products.

Consumers : Stop using the recalled products lots. Contact your veterinarian if your pets have experienced any problems that may be related to using the recalled products.

Distributors and retailers : Stop distribution, return any leftover recalled product to the manufacturer, or discard.

Veterinary hospitals, clinics, and other consignees : Return any unused product to the manufacturer or discard.

CONTACT AMERICAN REGENT INC.

Consumers and veterinary professionals with questions regarding this recall can contact American Regent Inc. using the below information.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA at 1-888-FDA-VETS or online at http://www.FDA.gov/reportanimalae .This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

American Regent, Inc. is committed to the safety of patients who rely on its products and is taking this precautionary action to protect public health.

Text from FDA (the company’s words), unedited.
  • Adequan Canine Injection, 100mg/1 mL 5 mL multi-dose vial

    Lot or code
    NADA: 141-038; Lot #: 3369; Distribution Date: 05/22/2024; Expiration Date: 10/31/2026 | NADA: 141-038; Lot #: 25011; Distribution Date: 04/14/2025; Expiration Date: 12/31/2027
  • Adequan i.m. Injection 500mg/5 mL 5 mL multi-dose vial

    Lot or code
    NADA: 140-901; Lot #: 24416; Distribution Date: 05/08/2025; Expiration Date: 11/30/2027 | NADA: 140-901; Lot #: 25265P; Distribution Date: 01/22/2026; Expiration Date: 03/31/2027

Source

Issued by
U.S. Food and Drug Administration
Firm
American Regent, Inc. Animal Health

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Month: July 2026, Week 2026-W31. Browse more medicines recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “Visible glass fiber material in the product”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

How do I know if my product is included?

Compare the lot or code printed on your product with the codes FDA lists on this notice, product by product.

How does the code check on this page work?

You type the lot, batch, date code, model number or UPC from your package and the page compares it, in your browser, with the codes FDA lists on this notice. It reports a match, a possible match (your code is part of a longer listed code) or no match. It only compares text: a notice that describes products by dates, sizes or “all lots” cannot be compared, so “no match” does not clear a product. The comparison runs in your browser and the page does not send the code anywhere, and the code stays out of the page address. Only if you press “Copy link to this result” is a link made that carries it, and whoever opens that link requests that address from this site.

When was this recall published?

FDA published this company announcement on July 31, 2026.